Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 23
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Pergola: boosting visualization and analysis of longitudinal data by unlocking genomic analysis tools

  • Espinosa-Carrasco, José
  • Erb, Ionas
  • Hermoso Pulido, Antonio
  • Ponomarenko, Julia
  • Dierssen, Mara
  • Notredame, Cedric
The growing appetite of behavioral neuroscience for automated data production is prompting the need for new computational standards allowing improved interoperability, reproducibility, and shareability. We show here how these issues can be solved by repurposing existing genomic formats whose structure perfectly supports the handling of time series. This allows existing genomic analysis and visualization tools to be deployed onto behavioral data. As a proof of principle, we implemented the conversion procedure in Pergola, an open source software, and used genomics tools to reproduce results obtained in mouse, fly, and worm. We also show how common genomics techniques such as principal component analysis, hidden Markov modeling, and volcano plots can be deployed on the reformatted behavioral data. These analyses are easy to share because they depend on the scripting of public software. They are also easy to reproduce thanks to their integration within Nextflow, a workflow manager using containerized software., We acknowledge the support of the “Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat i del Fons Social Europeu,” Spanish Ministry of Economy, Industry and Competitiveness (MEIC) under grant numbers BFU2014-55062-P and BFU2017-88264-P, the EMBL partnership, FEDER, the “Centro de Excelencia Severo Ochoa” Programme, and the CERCA Programme/Generalitat de Catalunya. This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 635290-PanCanRisk and OpenRiskNet_731076. This reflects only the author's view and the funder is not responsible for any use that may be made of the information it contains. M.D. is supported by DIUE de la Generalitat de Catalunya (Grups consolidats SGR 2017/926), the Fondation Jérôme Lejeune (Paris, France), MINECO (SAF2013-49129-C2-1-R; SAF2016-79956-R), CDTI (“Smartfoods”) and EU (EraNet Neuron PCIN-2013-060 and JPND AC17/00006), and the Catalan foundation “La Marató de TV3” (#2016/20-30). The CIBER of Rare Diseases is an initiative of the ISCIII.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Pergola-web: a web server for the visualization and analysis of longitudinal behavioral data using repurposed genomics tools and standards

  • Espinosa-Carrasco, José
  • Hermoso Pulido, Antonio
  • Erb, Ionas
  • Dierssen, Mara
  • Ponomarenko, Julia
  • Notredame, Cedric
We present a new web application to query and visualize time-series behavioral data: the Pergola web-server. This server provides a user-friendly interface for exploring longitudinal behavioral data taking advantage of the Pergola Python library. Using the server, users can process the data applying some basic operations, such as binning or grouping, while formatting the data into existing genomic formats. Thanks to this repurposing of genomics standards, the application automatically renders an interactive data visualization based on sophisticated genome visualization tools. Our tool allows behavioral scientists to share, display and navigate complex behavioral data comprising multiple individuals and multiple data types, in a scalable and flexible manner. A download option allows for further analysis using genomic tools. The server can be a great resource for the field in a time where behavioral science is entering a data-intensive cycle thanks to high-throughput behavioral phenotyping platforms. Pergola is publicly available at http://pergola.crg.eu/., 'Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat i del Fons Social Europeu', Spanish Ministry of Economy, Industry and Competitiveness (MEIC) [BFU2014-55062-P, BFU2017-88264-P]; EMBL partnership, FEDER, the ‘Centro de Excelencia Severo Ochoa’ Programme; CERCA Programme/Generalitatde Catalunya; European Union's Horizon 2020 research and innovation program [635290-PanCanRisk and OpenRiskNet_731076]; DIUE de la Generalitat de Catalunya [Grups consolidatsSGR 2017/926]; Fondation Jérôme Lejeune (Paris, France), MINECO [SAF2013-49129-C2-1-R;SAF2016-79956-R]; CDTI (‘Smartfoods’) and EU [EraNet Neuron PCIN-2013-060 and JPND AC17/00006]; Catalan foundation ‘La Marato′de TV3’ [2016/20-30]; CIBER of Rare Diseases is an initiative of the ISCIII. Funding for open access charge: CRG institutional core funding.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The rate and spectrum of mosaic mutations during embryogenesis revealed by RNA sequencing of 49 tissues

  • Muyas Remolar, Francesc, 1992-
  • Zapata Ortiz, Luis, 1985-
  • Guigó Serra, Roderic
  • Ossowski, Stephan
Background: Mosaic mutations acquired during early embryogenesis can lead to severe early-onset genetic disorders and cancer predisposition, but are often undetectable in blood samples. The rate and mutational spectrum of embryonic mosaic mutations (EMMs) have only been studied in few tissues, and their contribution to genetic disorders is unknown. Therefore, we investigated how frequent mosaic mutations occur during embryogenesis across all germ layers and tissues. Methods: Mosaic mutation detection in 49 normal tissues from 570 individuals (Genotype-Tissue Expression (GTEx) cohort) was performed using a newly developed multi-tissue, multi-individual variant calling approach for RNA-seq data. Our method allows for reliable identification of EMMs and the developmental stage during which they appeared. Results: The analysis of EMMs in 570 individuals revealed that newborns on average harbor 0.5-1 EMMs in the exome affecting multiple organs (1.3230 × 10-8 per nucleotide per individual), a similar frequency as reported for germline de novo mutations. Our multi-tissue, multi-individual study design allowed us to distinguish mosaic mutations acquired during different stages of embryogenesis and adult life, as well as to provide insights into the rate and spectrum of mosaic mutations. We observed that EMMs are dominated by a mutational signature associated with spontaneous deamination of methylated cytosines and the number of cell divisions. After birth, cells continue to accumulate somatic mutations, which can lead to the development of cancer. Investigation of the mutational spectrum of the gastrointestinal tract revealed a mutational pattern associated with the food-borne carcinogen aflatoxin, a signature that has so far only been reported in liver cancer. Conclusions: In summary, our multi-tissue, multi-individual study reveals a surprisingly high number of embryonic mosaic mutations in coding regions, implying novel hypotheses and diagnostic procedures for investigating genetic causes of disease and cancer predisposition., This project has received funding from the European Union’s H2020 research and innovation programme under grant agreement no. 635290 (PanCanRisk). We acknowledge support by the Faculty of Medicine of the University of Tübingen, the Spanish Ministry of Economy and Competitiveness, “Centro de Excelencia Severo Ochoa 2013-2017,” SEV-2012-0208, and the CERCA Programme/Generalitat de Catalunya. LZ is supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Research Fellowship scheme (846614).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

eDiVA-Classification and prioritization of pathogenic variants for clinical diagnostics

  • Bosio, Mattia
  • Drechsel, Oliver
  • Rahman, Rubayte
  • Muyas Remolar, Francesc, 1992-
  • Rabionet Janssen, Raquel
  • Bezdan, Daniela
  • Domènech Salgado, Laura, 1989-
  • Hor, Hyun
  • Schott, Jean-Jacques
  • Munell, Francina
  • Colobran, Roger
  • Macaya, Alfons
  • Estivill, Xavier, 1955-
  • Ossowski, Stephan
Mendelian diseases have shown to be an and efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20-30% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here, we present the exome Disease Variant Analysis (eDiVA; http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing single-nucleotide variants and small insertions and deletions) for rare diseases using WES of families or parent-child trios. eDiVA combines next-generation sequencing data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning-based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates that eDiVA consistently performed as a good or better than existing approach in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability., This project has received funding from the “la Caixa” Foundation, the CRG emergent translational research award and the European Union's H2020 Research and Innovation Programme under the grant agreement No 635290 (PanCanRisk).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Allele balance bias identifies systematic genotyping errors and false disease associations

  • Muyas Remolar, Francesc, 1992-
  • Bosio, Mattia
  • Puig, Anna
  • Sušak, Hana, 1985-
  • Domènech Salgado, Laura, 1989-
  • Escaramís, Geòrgia
  • Zapata Ortiz, Luis, 1985-
  • Demidov, German, 1990-
  • Estivill, Xavier, 1955-
  • Rabionet Janssen, Raquel
  • Ossowski, Stephan
In recent years, next-generation sequencing (NGS) has become a cornerstone of clinical genetics and diagnostics. Many clinical applications require high precision, especially if rare events such as somatic mutations in cancer or genetic variants causing rare diseases need to be identified. Although random sequencing errors can be modeled statistically and deep sequencing minimizes their impact, systematic errors remain a problem even at high depth of coverage. Understanding their source is crucial to increase precision of clinical NGS applications. In this work, we studied the relation between recurrent biases in allele balance (AB), systematic errors, and false positive variant calls across a large cohort of human samples analyzed by whole exome sequencing (WES). We have modeled the AB distribution for biallelic genotypes in 987 WES samples in order to identify positions recurrently deviating significantly from the expectation, a phenomenon we termed allele balance bias (ABB). Furthermore, we have developed a genotype callability score based on ABB for all positions of the human exome, which detects false positive variant calls that passed state-of-the-art filters. Finally, we demonstrate the use of ABB for detection of false associations proposed by rare variant association studies. Availability: https://github.com/Francesc-Muyas/ABB., Spanish Ministry of Economy and Competitiveness, Grant/Award Number: ‘Centro de Excelencia Severo Ochoa 2017–2021’; CERCA Programme/Generalitat de Catalunya; The “la Caixa” Foundation; CRG Emergent Translational Research Award; European Union's H2020 Research and Innovation Programme, Grant/Award Number: 635290 (PanCanRisk); MINECO Severo Ochoa Fellowship, Grant/Award Number: SVP‐2013‐0680066; PERIS Program, Grant/Award Number: SLT002/16/00310.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Signatures of positive selection reveal a universal role of chromatin modifiers as cancer driver genes

  • Zapata Ortiz, Luis, 1985-
  • Sušak, Hana, 1985-
  • Drechsel, Oliver
  • Friedländer, Marc R.
  • Estivill, Xavier, 1955-
  • Ossowski, Stephan
Tumors are composed of an evolving population of cells subjected to tissue-specific selection, which fuels tumor heterogeneity and ultimately complicates cancer driver gene identification. Here, we integrate cancer cell fraction, population recurrence, and functional impact of somatic mutations as signatures of selection into a Bayesian model for driver prediction. We demonstrate that our model, cDriver, outperforms competing methods when analyzing solid tumors, hematological malignancies, and pan-cancer datasets. Applying cDriver to exome sequencing data of 21 cancer types from 6,870 individuals revealed 98 unreported tumor type-driver gene connections. These novel connections are highly enriched for chromatin-modifying proteins, hinting at a universal role of chromatin regulation in cancer etiology. Although infrequently mutated as single genes, we show that chromatin modifiers are altered in a large fraction of cancer patients. In summary, we demonstrate that integration of evolutionary signatures is key for identifying mutational driver genes, thereby facilitating the discovery of novel therapeutic targets for cancer treatment., We acknowledge support of the Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa 2013-2017'. We acknowledge the support of the CERCA Programme/Generalitat de Catalunya. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 635290. Luis Zapata has been supported by the International PhD scholarship program of La Caixa at CRG.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Efficient and flexible Integration of variant characteristics in rare variant association studies using integrated nested Laplace approximation

  • Sušak, Hana, 1985-
  • Serra Saurina, Laura
  • Demidov, German, 1990-
  • Rabionet Janssen, Raquel
  • Domènech Salgado, Laura, 1989-
  • Bosio, Mattia
  • Muyas Remolar, Francesc, 1992-
  • Estivill, Xavier, 1955-
  • Escaramís, Geòrgia
  • Ossowski, Stephan
Rare variants are thought to play an important role in the etiology of complex diseases and may explain a significant fraction of the missing heritability in genetic disease studies. Next-generation sequencing facilitates the association of rare variants in coding or regulatory regions with complex diseases in large cohorts at genome-wide scale. However, rare variant association studies (RVAS) still lack power when cohorts are small to medium-sized and if genetic variation explains a small fraction of phenotypic variance. Here we present a novel Bayesian rare variant Association Test using Integrated Nested Laplace Approximation (BATI). Unlike existing RVAS tests, BATI allows integration of individual or variant-specific features as covariates, while efficiently performing inference based on full model estimation. We demonstrate that BATI outperforms established RVAS methods on realistic, semi-synthetic whole-exome sequencing cohorts, especially when using meaningful biological context, such as functional annotation. We show that BATI achieves power above 70% in scenarios in which competing tests fail to identify risk genes, e.g. when risk variants in sum explain less than 0.5% of phenotypic variance. We have integrated BATI, together with five existing RVAS tests in the 'Rare Variant Genome Wide Association Study' (rvGWAS) framework for data analyzed by whole-exome or whole genome sequencing. rvGWAS supports rare variant association for genes or any other biological unit such as promoters, while allowing the analysis of essential functionalities like quality control or filtering. Applying rvGWAS to a Chronic Lymphocytic Leukemia study we identified eight candidate predisposition genes, including EHMT2 and COPS7A., Funding: SO, HS, XE, FM and GD received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 635290 (PanCanRisk). SO and GD received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779257 (Solve-RD). RR received support from the Fundació La Marató 70/307:201726. HS, GD, RR, LD, MB, FM, XE, GE and SO received support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017, and the CERCA Programme / Generalitat de Catalunya
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Negative selection in tumor genome evolution acts on essential cellular functions and the immunopeptidome

  • Zapata Ortiz, Luis, 1985-
  • Pich Roselló, Oriol, 1992-
  • Serrano Pubull, Luis, 1982-
  • Kondrashov, Fyodor A., 1979-
  • Ossowski, Stephan
  • Schaefer, Martin H.
Background: Natural selection shapes cancer genomes. Previous studies used signatures of positive selection to identify genes driving malignant transformation. However, the contribution of negative selection against somatic mutations that affect essential tumor functions or specific domains remains a controversial topic. Results: Here, we analyze 7546 individual exomes from 26 tumor types from TCGA data to explore the portion of the cancer exome under negative selection. Although we find most of the genes neutrally evolving in a pan-cancer framework, we identify essential cancer genes and immune-exposed protein regions under significant negative selection. Moreover, our simulations suggest that the amount of negative selection is underestimated. We therefore choose an empirical approach to identify genes, functions, and protein regions under negative selection. We find that expression and mutation status of negatively selected genes is indicative of patient survival. Processes that are most strongly conserved are those that play fundamental cellular roles such as protein synthesis, glucose metabolism, and molecular transport. Intriguingly, we observe strong signals of selection in the immunopeptidome and proteins controlling peptide exposition, highlighting the importance of immune surveillance evasion. Additionally, tumor type-specific immune activity correlates with the strength of negative selection on human epitopes. Conclusions: In summary, our results show that negative selection is a hallmark of cell essentiality and immune response in cancer. The functional domains identified could be exploited therapeutically, ultimately allowing for the development of novel cancer treatments., The research leading to these results received funding from the Spanish Ministry of Economy—, Industry and Competitiveness (Plan Nacional BIO2012-39754, BFU2012-31329 and BFU2015-68723-P and to the EMBL partnership), “Centro de Excelencia Severo Ochoa 2013–2017,” SEV-2012–0208, the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement nº. HEALTH-F4-2011–278568 (PRIMES), the European Fund for Regional Development (EFRD), European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 635290 (PanCanRisk), CERCA Programme / Generalitat de Catalunya, the HHMI International Early Career Scientist Program (55007424), Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat’s AGAUR program (2014 SGR 0974), and the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013, ERC grant agreement 335980_EinME). LZ has been supported by the International PhD scholarship program of La Caixa at CRG and MS by the German Research Foundation (SCHA 1933/1-1).
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

eDiVA - Classification and prioritization of pathogenic variants for clinical diagnostics

  • Bosio, Mattia
  • Drechsel, Oliver
  • Rahman, Rubayte
  • Muyas, Francesc
  • Rabionet Janssen, Raquel
  • Bezdan, Daniela
  • Domenech Salgado, Laura
  • Hor, Hyun G.
  • Schott, Jean-Jacques
  • Munell Casadesús, Francina
  • Colobran, Roger
  • Macaya Ruiz, Alfons
  • Estivill, Xavier, 1955-
  • Ossowski, Stephan
Mendelian diseases have shown to be an efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20-30% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here we present eDiVA (http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing SNVs and InDels) for rare diseases using WES of families or parent-child trios. eDiVA combines NGS data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state of the art competitors demonstrates that eDiVA consistently performed as good or better than existing approaches in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Efficient and flexible Integration of variant characteristics in rare variant association studies using integrated nested Laplace approximation

  • Susak, Hana
  • Serra-Saurina, Laura
  • Demidov, German
  • Rabionet Janssen, Raquel
  • Domènech, Laura
  • Bosio, Mattia
  • Muyas, Francesc
  • Estivill, Xavier, 1955-
  • Escaramís Babiano, Geòrgia
  • Ossowski, Stephan
Rare variants are thought to play an important role in the etiology of complex diseases and may explain a significant fraction of the missing heritability in genetic disease studies. Next-generation sequencing facilitates the association of rare variants in coding or regulatory regions with complex diseases in large cohorts at genome-wide scale. However, rare variant association studies (RVAS) still lack power when cohorts are small to medium-sized and if genetic variation explains a small fraction of phenotypic variance. Here we present a novel Bayesian rare variant Association Test using Integrated Nested Laplace Approximation (BATI). Unlike existing RVAS tests, BATI allows integration of individual or variant-specific features as covariates, while efficiently performing inference based on full model estimation. We demonstrate that BATI outperforms established RVAS methods on realistic, semi-synthetic whole-exome sequencing cohorts, especially when using meaningful biological context, such as functional annotation. We show that BATI achieves power above 70% in scenarios in which competing tests fail to identify risk genes, e.g. when risk variants in sum explain less than 0.5% of phenotypic variance. We have integrated BATI, together with five existing RVAS tests in the 'Rare Variant Genome Wide Association Study' (rvGWAS) framework for data analyzed by whole-exome or whole genome sequencing. rvGWAS supports rare variant association for genes or any other biological unit such as promoters, while allowing the analysis of essential functionalities like quality control or filtering. Applying rvGWAS to a Chronic Lymphocytic Leukemia study we identified eight candidate predisposition genes, including EHMT2 and COPS7A.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Allele balance bias identifies systematic genotyping errors and false disease associations

  • Muyas, Francesc
  • Bosio, Mattia
  • Puig, Anna
  • Susak, Hana
  • Domènech, Laura
  • Escaramís Babiano, Geòrgia
  • Zapata, Luis
  • Demidov, German
  • Estivill, Xavier, 1955-
  • Rabionet Janssen, Raquel
  • Ossowski, Stephan
In recent years, next‐generation sequencing (NGS) has become a cornerstone of clinical genetics and diagnostics. Many clinical applications require high precision, especially if rare events such as somatic mutations in cancer or genetic variants causing rare diseases need to be identified. Although random sequencing errors can be modeled statistically and deep sequencing minimizes their impact, systematic errors remain a problem even at high depth of coverage. Understanding their source is crucial to increase precision of clinical NGS applications. In this work, we studied the relation between recurrent biases in allele balance (AB), systematic errors, and false positive variant calls across a large cohort of human samples analyzed by whole exome sequencing (WES). We have modeled the AB distribution for biallelic genotypes in 987 WES samples in order to identify positions recurrently deviating significantly from the expectation, a phenomenon we termed allele balance bias (ABB). Furthermore, we have developed a genotype callability score based on ABB for all positions of the human exome, which detects false positive variant calls that passed state‐of‐the‐art filters. Finally, we demonstrate the use of ABB for detection of false associations proposed by rare variant association studies. Availability: https://github.com/Francesc-Muyas/ABB.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Negative selection in tumor genome evolution acts on essential cellular functions and the immunopeptidome

  • Zapata Ortiz, Luis, 1985-
  • Pich Roselló, Oriol, 1992-
  • Serrano Pubull, Luis, 1982-
  • Kondrashov, Fyodor A., 1979-
  • Ossowski, Stephan
  • Schaefer, Martin H.
Background: Natural selection shapes cancer genomes. Previous studies used signatures of positive selection to identify genes driving malignant transformation. However, the contribution of negative selection against somatic mutations that affect essential tumor functions or specific domains remains a controversial topic. Results: Here, we analyze 7546 individual exomes from 26 tumor types from TCGA data to explore the portion of the cancer exome under negative selection. Although we find most of the genes neutrally evolving in a pan-cancer framework, we identify essential cancer genes and immune-exposed protein regions under significant negative selection. Moreover, our simulations suggest that the amount of negative selection is underestimated. We therefore choose an empirical approach to identify genes, functions, and protein regions under negative selection. We find that expression and mutation status of negatively selected genes is indicative of patient survival. Processes that are most strongly conserved are those that play fundamental cellular roles such as protein synthesis, glucose metabolism, and molecular transport. Intriguingly, we observe strong signals of selection in the immunopeptidome and proteins controlling peptide exposition, highlighting the importance of immune surveillance evasion. Additionally, tumor type-specific immune activity correlates with the strength of negative selection on human epitopes. Conclusions: In summary, our results show that negative selection is a hallmark of cell essentiality and immune response in cancer. The functional domains identified could be exploited therapeutically, ultimately allowing for the development of novel cancer treatments., The research leading to these results received funding from the Spanish Ministry of Economy—, Industry and Competitiveness (Plan Nacional BIO2012-39754, BFU2012-31329 and BFU2015-68723-P and to the EMBL partnership), “Centro de Excelencia Severo Ochoa 2013–2017,” SEV-2012–0208, the European Union Seventh Framework Programme (FP7/2007–2013) under grant agreement nº. HEALTH-F4-2011–278568 (PRIMES), the European Fund for Regional Development (EFRD), European Union’s Horizon 2020 research and innovation programme under grant agreement Nº 635290 (PanCanRisk), CERCA Programme / Generalitat de Catalunya, the HHMI International Early Career Scientist Program (55007424), Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat’s AGAUR program (2014 SGR 0974), and the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013, ERC grant agreement 335980_EinME). LZ has been supported by the International PhD scholarship program of La Caixa at CRG and MS by the German Research Foundation (SCHA 1933/1-1).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Allele balance bias identifies systematic genotyping errors and false disease associations

  • Muyas Remolar, Francesc, 1992-
  • Bosio, Mattia
  • Puig, Anna
  • Sušak, Hana, 1985-
  • Domènech Salgado, Laura, 1989-
  • Escaramís, Geòrgia
  • Zapata Ortiz, Luis, 1985-
  • Demidov, German, 1990-
  • Estivill, Xavier, 1955-
  • Rabionet Janssen, Raquel
  • Ossowski, Stephan
In recent years, next-generation sequencing (NGS) has become a cornerstone of clinical genetics and diagnostics. Many clinical applications require high precision, especially if rare events such as somatic mutations in cancer or genetic variants causing rare diseases need to be identified. Although random sequencing errors can be modeled statistically and deep sequencing minimizes their impact, systematic errors remain a problem even at high depth of coverage. Understanding their source is crucial to increase precision of clinical NGS applications. In this work, we studied the relation between recurrent biases in allele balance (AB), systematic errors, and false positive variant calls across a large cohort of human samples analyzed by whole exome sequencing (WES). We have modeled the AB distribution for biallelic genotypes in 987 WES samples in order to identify positions recurrently deviating significantly from the expectation, a phenomenon we termed allele balance bias (ABB). Furthermore, we have developed a genotype callability score based on ABB for all positions of the human exome, which detects false positive variant calls that passed state-of-the-art filters. Finally, we demonstrate the use of ABB for detection of false associations proposed by rare variant association studies. Availability: https://github.com/Francesc-Muyas/ABB., Spanish Ministry of Economy and Competitiveness, Grant/Award Number: ‘Centro de Excelencia Severo Ochoa 2017–2021’; CERCA Programme/Generalitat de Catalunya; The “la Caixa” Foundation; CRG Emergent Translational Research Award; European Union's H2020 Research and Innovation Programme, Grant/Award Number: 635290 (PanCanRisk); MINECO Severo Ochoa Fellowship, Grant/Award Number: SVP‐2013‐0680066; PERIS Program, Grant/Award Number: SLT002/16/00310.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Pergola: boosting visualization and analysis of longitudinal data by unlocking genomic analysis tools

  • Espinosa-Carrasco, José
  • Erb, Ionas
  • Hermoso Pulido, Antonio
  • Ponomarenko, Julia
  • Dierssen, Mara
  • Notredame, Cedric
The growing appetite of behavioral neuroscience for automated data production is prompting the need for new computational standards allowing improved interoperability, reproducibility, and shareability. We show here how these issues can be solved by repurposing existing genomic formats whose structure perfectly supports the handling of time series. This allows existing genomic analysis and visualization tools to be deployed onto behavioral data. As a proof of principle, we implemented the conversion procedure in Pergola, an open source software, and used genomics tools to reproduce results obtained in mouse, fly, and worm. We also show how common genomics techniques such as principal component analysis, hidden Markov modeling, and volcano plots can be deployed on the reformatted behavioral data. These analyses are easy to share because they depend on the scripting of public software. They are also easy to reproduce thanks to their integration within Nextflow, a workflow manager using containerized software., We acknowledge the support of the “Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat i del Fons Social Europeu,” Spanish Ministry of Economy, Industry and Competitiveness (MEIC) under grant numbers BFU2014-55062-P and BFU2017-88264-P, the EMBL partnership, FEDER, the “Centro de Excelencia Severo Ochoa” Programme, and the CERCA Programme/Generalitat de Catalunya. This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 635290-PanCanRisk and OpenRiskNet_731076. This reflects only the author's view and the funder is not responsible for any use that may be made of the information it contains. M.D. is supported by DIUE de la Generalitat de Catalunya (Grups consolidats SGR 2017/926), the Fondation Jérôme Lejeune (Paris, France), MINECO (SAF2013-49129-C2-1-R; SAF2016-79956-R), CDTI (“Smartfoods”) and EU (EraNet Neuron PCIN-2013-060 and JPND AC17/00006), and the Catalan foundation “La Marató de TV3” (#2016/20-30). The CIBER of Rare Diseases is an initiative of the ISCIII.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Efficient and flexible Integration of variant characteristics in rare variant association studies using integrated nested Laplace approximation

  • Sušak, Hana, 1985-
  • Serra Saurina, Laura
  • Demidov, German, 1990-
  • Rabionet Janssen, Raquel
  • Domènech Salgado, Laura, 1989-
  • Bosio, Mattia
  • Muyas Remolar, Francesc, 1992-
  • Estivill, Xavier, 1955-
  • Escaramís, Geòrgia
  • Ossowski, Stephan
Rare variants are thought to play an important role in the etiology of complex diseases and may explain a significant fraction of the missing heritability in genetic disease studies. Next-generation sequencing facilitates the association of rare variants in coding or regulatory regions with complex diseases in large cohorts at genome-wide scale. However, rare variant association studies (RVAS) still lack power when cohorts are small to medium-sized and if genetic variation explains a small fraction of phenotypic variance. Here we present a novel Bayesian rare variant Association Test using Integrated Nested Laplace Approximation (BATI). Unlike existing RVAS tests, BATI allows integration of individual or variant-specific features as covariates, while efficiently performing inference based on full model estimation. We demonstrate that BATI outperforms established RVAS methods on realistic, semi-synthetic whole-exome sequencing cohorts, especially when using meaningful biological context, such as functional annotation. We show that BATI achieves power above 70% in scenarios in which competing tests fail to identify risk genes, e.g. when risk variants in sum explain less than 0.5% of phenotypic variance. We have integrated BATI, together with five existing RVAS tests in the 'Rare Variant Genome Wide Association Study' (rvGWAS) framework for data analyzed by whole-exome or whole genome sequencing. rvGWAS supports rare variant association for genes or any other biological unit such as promoters, while allowing the analysis of essential functionalities like quality control or filtering. Applying rvGWAS to a Chronic Lymphocytic Leukemia study we identified eight candidate predisposition genes, including EHMT2 and COPS7A., Funding: SO, HS, XE, FM and GD received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 635290 (PanCanRisk). SO and GD received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779257 (Solve-RD). RR received support from the Fundació La Marató 70/307:201726. HS, GD, RR, LD, MB, FM, XE, GE and SO received support of the Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017, and the CERCA Programme / Generalitat de Catalunya
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

eDiVA - Classification and prioritization of pathogenic variants for clinical diagnostics

  • Bosio, Mattia
  • Drechsel, Oliver
  • Rahman, Rubayte
  • Muyas, Francesc
  • Rabionet Janssen, Raquel
  • Bezdan, Daniela
  • Domenech Salgado, Laura
  • Hor, Hyun G.
  • Schott, Jean-Jacques
  • Munell Casadesús, Francina
  • Colobran, Roger
  • Macaya Ruiz, Alfons
  • Estivill, Xavier, 1955-
  • Ossowski, Stephan
Mendelian diseases have shown to be an efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20-30% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here we present eDiVA (http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing SNVs and InDels) for rare diseases using WES of families or parent-child trios. eDiVA combines NGS data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state of the art competitors demonstrates that eDiVA consistently performed as good or better than existing approaches in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

eDiVA-Classification and prioritization of pathogenic variants for clinical diagnostics

  • Bosio, Mattia
  • Drechsel, Oliver
  • Rahman, Rubayte
  • Muyas Remolar, Francesc, 1992-
  • Rabionet Janssen, Raquel
  • Bezdan, Daniela
  • Domènech Salgado, Laura, 1989-
  • Hor, Hyun
  • Schott, Jean-Jacques
  • Munell, Francina
  • Colobran, Roger
  • Macaya, Alfons
  • Estivill, Xavier, 1955-
  • Ossowski, Stephan
Mendelian diseases have shown to be an and efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20-30% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here, we present the exome Disease Variant Analysis (eDiVA; http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing single-nucleotide variants and small insertions and deletions) for rare diseases using WES of families or parent-child trios. eDiVA combines next-generation sequencing data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning-based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates that eDiVA consistently performed as a good or better than existing approach in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability., This project has received funding from the “la Caixa” Foundation, the CRG emergent translational research award and the European Union's H2020 Research and Innovation Programme under the grant agreement No 635290 (PanCanRisk).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Allele balance bias identifies systematic genotyping errors and false disease associations

  • Muyas, Francesc
  • Bosio, Mattia
  • Puig, Anna
  • Susak, Hana
  • Domènech, Laura
  • Escaramís Babiano, Geòrgia
  • Zapata, Luis
  • Demidov, German
  • Estivill, Xavier, 1955-
  • Rabionet Janssen, Raquel
  • Ossowski, Stephan
In recent years, next‐generation sequencing (NGS) has become a cornerstone of clinical genetics and diagnostics. Many clinical applications require high precision, especially if rare events such as somatic mutations in cancer or genetic variants causing rare diseases need to be identified. Although random sequencing errors can be modeled statistically and deep sequencing minimizes their impact, systematic errors remain a problem even at high depth of coverage. Understanding their source is crucial to increase precision of clinical NGS applications. In this work, we studied the relation between recurrent biases in allele balance (AB), systematic errors, and false positive variant calls across a large cohort of human samples analyzed by whole exome sequencing (WES). We have modeled the AB distribution for biallelic genotypes in 987 WES samples in order to identify positions recurrently deviating significantly from the expectation, a phenomenon we termed allele balance bias (ABB). Furthermore, we have developed a genotype callability score based on ABB for all positions of the human exome, which detects false positive variant calls that passed state‐of‐the‐art filters. Finally, we demonstrate the use of ABB for detection of false associations proposed by rare variant association studies. Availability: https://github.com/Francesc-Muyas/ABB.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Signatures of positive selection reveal a universal role of chromatin modifiers as cancer driver genes

  • Zapata Ortiz, Luis, 1985-
  • Sušak, Hana, 1985-
  • Drechsel, Oliver
  • Friedländer, Marc R.
  • Estivill, Xavier, 1955-
  • Ossowski, Stephan
Tumors are composed of an evolving population of cells subjected to tissue-specific selection, which fuels tumor heterogeneity and ultimately complicates cancer driver gene identification. Here, we integrate cancer cell fraction, population recurrence, and functional impact of somatic mutations as signatures of selection into a Bayesian model for driver prediction. We demonstrate that our model, cDriver, outperforms competing methods when analyzing solid tumors, hematological malignancies, and pan-cancer datasets. Applying cDriver to exome sequencing data of 21 cancer types from 6,870 individuals revealed 98 unreported tumor type-driver gene connections. These novel connections are highly enriched for chromatin-modifying proteins, hinting at a universal role of chromatin regulation in cancer etiology. Although infrequently mutated as single genes, we show that chromatin modifiers are altered in a large fraction of cancer patients. In summary, we demonstrate that integration of evolutionary signatures is key for identifying mutational driver genes, thereby facilitating the discovery of novel therapeutic targets for cancer treatment., We acknowledge support of the Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa 2013-2017'. We acknowledge the support of the CERCA Programme/Generalitat de Catalunya. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 635290. Luis Zapata has been supported by the International PhD scholarship program of La Caixa at CRG.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The rate and spectrum of mosaic mutations during embryogenesis revealed by RNA sequencing of 49 tissues

  • Muyas Remolar, Francesc, 1992-
  • Zapata Ortiz, Luis, 1985-
  • Guigó Serra, Roderic
  • Ossowski, Stephan
Background: Mosaic mutations acquired during early embryogenesis can lead to severe early-onset genetic disorders and cancer predisposition, but are often undetectable in blood samples. The rate and mutational spectrum of embryonic mosaic mutations (EMMs) have only been studied in few tissues, and their contribution to genetic disorders is unknown. Therefore, we investigated how frequent mosaic mutations occur during embryogenesis across all germ layers and tissues. Methods: Mosaic mutation detection in 49 normal tissues from 570 individuals (Genotype-Tissue Expression (GTEx) cohort) was performed using a newly developed multi-tissue, multi-individual variant calling approach for RNA-seq data. Our method allows for reliable identification of EMMs and the developmental stage during which they appeared. Results: The analysis of EMMs in 570 individuals revealed that newborns on average harbor 0.5-1 EMMs in the exome affecting multiple organs (1.3230 × 10-8 per nucleotide per individual), a similar frequency as reported for germline de novo mutations. Our multi-tissue, multi-individual study design allowed us to distinguish mosaic mutations acquired during different stages of embryogenesis and adult life, as well as to provide insights into the rate and spectrum of mosaic mutations. We observed that EMMs are dominated by a mutational signature associated with spontaneous deamination of methylated cytosines and the number of cell divisions. After birth, cells continue to accumulate somatic mutations, which can lead to the development of cancer. Investigation of the mutational spectrum of the gastrointestinal tract revealed a mutational pattern associated with the food-borne carcinogen aflatoxin, a signature that has so far only been reported in liver cancer. Conclusions: In summary, our multi-tissue, multi-individual study reveals a surprisingly high number of embryonic mosaic mutations in coding regions, implying novel hypotheses and diagnostic procedures for investigating genetic causes of disease and cancer predisposition., This project has received funding from the European Union’s H2020 research and innovation programme under grant agreement no. 635290 (PanCanRisk). We acknowledge support by the Faculty of Medicine of the University of Tübingen, the Spanish Ministry of Economy and Competitiveness, “Centro de Excelencia Severo Ochoa 2013-2017,” SEV-2012-0208, and the CERCA Programme/Generalitat de Catalunya. LZ is supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Research Fellowship scheme (846614).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Pergola-web: a web server for the visualization and analysis of longitudinal behavioral data using repurposed genomics tools and standards

  • Espinosa-Carrasco, José
  • Hermoso Pulido, Antonio
  • Erb, Ionas
  • Dierssen, Mara
  • Ponomarenko, Julia
  • Notredame, Cedric
We present a new web application to query and visualize time-series behavioral data: the Pergola web-server. This server provides a user-friendly interface for exploring longitudinal behavioral data taking advantage of the Pergola Python library. Using the server, users can process the data applying some basic operations, such as binning or grouping, while formatting the data into existing genomic formats. Thanks to this repurposing of genomics standards, the application automatically renders an interactive data visualization based on sophisticated genome visualization tools. Our tool allows behavioral scientists to share, display and navigate complex behavioral data comprising multiple individuals and multiple data types, in a scalable and flexible manner. A download option allows for further analysis using genomic tools. The server can be a great resource for the field in a time where behavioral science is entering a data-intensive cycle thanks to high-throughput behavioral phenotyping platforms. Pergola is publicly available at http://pergola.crg.eu/., 'Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat i del Fons Social Europeu', Spanish Ministry of Economy, Industry and Competitiveness (MEIC) [BFU2014-55062-P, BFU2017-88264-P]; EMBL partnership, FEDER, the ‘Centro de Excelencia Severo Ochoa’ Programme; CERCA Programme/Generalitatde Catalunya; European Union's Horizon 2020 research and innovation program [635290-PanCanRisk and OpenRiskNet_731076]; DIUE de la Generalitat de Catalunya [Grups consolidatsSGR 2017/926]; Fondation Jérôme Lejeune (Paris, France), MINECO [SAF2013-49129-C2-1-R;SAF2016-79956-R]; CDTI (‘Smartfoods’) and EU [EraNet Neuron PCIN-2013-060 and JPND AC17/00006]; Catalan foundation ‘La Marato′de TV3’ [2016/20-30]; CIBER of Rare Diseases is an initiative of the ISCIII. Funding for open access charge: CRG institutional core funding.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Efficient and flexible Integration of variant characteristics in rare variant association studies using integrated nested Laplace approximation

  • Susak, Hana
  • Serra-Saurina, Laura
  • Demidov, German
  • Rabionet Janssen, Raquel
  • Domènech, Laura
  • Bosio, Mattia
  • Muyas, Francesc
  • Estivill, Xavier, 1955-
  • Escaramís Babiano, Geòrgia
  • Ossowski, Stephan
Rare variants are thought to play an important role in the etiology of complex diseases and may explain a significant fraction of the missing heritability in genetic disease studies. Next-generation sequencing facilitates the association of rare variants in coding or regulatory regions with complex diseases in large cohorts at genome-wide scale. However, rare variant association studies (RVAS) still lack power when cohorts are small to medium-sized and if genetic variation explains a small fraction of phenotypic variance. Here we present a novel Bayesian rare variant Association Test using Integrated Nested Laplace Approximation (BATI). Unlike existing RVAS tests, BATI allows integration of individual or variant-specific features as covariates, while efficiently performing inference based on full model estimation. We demonstrate that BATI outperforms established RVAS methods on realistic, semi-synthetic whole-exome sequencing cohorts, especially when using meaningful biological context, such as functional annotation. We show that BATI achieves power above 70% in scenarios in which competing tests fail to identify risk genes, e.g. when risk variants in sum explain less than 0.5% of phenotypic variance. We have integrated BATI, together with five existing RVAS tests in the 'Rare Variant Genome Wide Association Study' (rvGWAS) framework for data analyzed by whole-exome or whole genome sequencing. rvGWAS supports rare variant association for genes or any other biological unit such as promoters, while allowing the analysis of essential functionalities like quality control or filtering. Applying rvGWAS to a Chronic Lymphocytic Leukemia study we identified eight candidate predisposition genes, including EHMT2 and COPS7A.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

eDiVA-Classification and prioritization of pathogenic variants for clinical diagnostics

  • Bosio, Mattia
  • Drechsel, Oliver
  • Rahman, Rubayte
  • Muyas, Francesc|||0000-0002-7857-0623
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Bezdan, Daniela
  • Domenech Salgado, Laura
  • Hor, Hyun
  • Schott, Jean-Jacques
  • Munell Casadesus, Francina|||0000-0001-8580-2819
  • Colobrán Oriol, Roger|||0000-0002-5964-536X
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Estivill, Xavier|||0000-0002-0723-2256
  • Ossowski, Stephan|||0000-0002-7416-9568
Mendelian diseases have shown to be an and efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20-30% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here, we present the exome Disease Variant Analysis (eDiVA; http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing single-nucleotide variants and small insertions and deletions) for rare diseases using WES of families or parent-child trios. eDiVA combines next-generation sequencing data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning-based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates that eDiVA consistently performed as a good or better than existing approach in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability.